Bliss GVS Pharma Ltd. - Quarterly/Annual Result Disclosures and Notes dated 31 Dec 2018
Auditor and Management Disclosures and Notes for the quarterly results dated 31 Dec 2018
1 The above results which are published in accordance with Regulation 33 of the SEBI (Listing Obligation1 The above results which are published in accordance with Regulation 33 of the SEBI (Listing Obligation& Disclosure Requirements), 2015 have been reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on January 29, 2019. The financial results are in accordance with the Indian Accounting Standards (Ind AS) as prescribed under Section 133 of the Companies Act, 2013 read with Rule 7 of the Companies (Indian Accounting Standards) Rules, 2015 and Companies (Indian Accounting Standards) Amendment Rules, 2016. The Statutory Auditors of the company have carried out a Limited Review of the above results.
2 The Ministry of Corporate Affairs (MCA), on 28th March, 2018, notified lnd AS 115 "Revenue from Contracts with Customers" as part of the Companies (Indian Accounting Standards) Amendment Rules, 2018 and the same is effective for accounting periods beginning on or after 1st April, 2018. The adoption of this standard did not have any material impact to the financial statements of the Company.
3 As the Company's business activity falls within a single operating segment viz. "Pharmaceutical and Healthcare", no segment information is disclosed.
4 During the quarter ended March 31, 2018 a material stepdown subsidiary namely Bliss GVS Healthcare Limited, Nairobi was disinvested and the analysis of revenue, expenses and profit & loss of discontinuing operations has been disclosed in consolidated results for the year ended March 31, 2018 as per para 33(b) of Ind AS 105 ‘Non-Current Assets held for Sale and Discontinuing Operations’. Accordingly, Revenue from operations and expenses for the quarter and the nine months ended December 31, 2018 is not comparable with the quarter and nine months ended December 31, 2017.
5 Other income includes foreign exchange loss of Rs.605.92Lakhs in standalone and consolidated financial result for the quarter ended December 31, 2018.
6 The figures for the quarter ended December 31, 2018 are the balancing figures between unaudited figures in respect of the nine months ended December 31,2018 and the year to date published result for the half year ended September 30,2018 .
7 Previous year figures have been regrouped/reclassified wherever necessary.